+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Agomelatine"

Treatment Resistant Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Global and Chinese Agomelatine Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Agomelatine Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 141 Pages
  • China, Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Agomelatine is a drug used to treat mental disorders, such as major depressive disorder and generalized anxiety disorder. It is a melatonergic antidepressant, meaning it works by affecting the levels of melatonin in the brain. Agomelatine is thought to be more effective than traditional antidepressants, as it has fewer side effects and is better tolerated. It is also believed to be more effective in treating sleep disturbances associated with depression. Agomelatine is available in many countries, including the United States, Canada, the United Kingdom, and Australia. It is available in both generic and brand-name forms. The market for agomelatine is growing, as more people are turning to it as an alternative to traditional antidepressants. It is becoming increasingly popular as a treatment for mental disorders, as it is believed to be more effective and have fewer side effects. Some companies in the agomelatine market include Lundbeck, Servier, and Mylan. Show Less Read more